Abstract：
A unique dermatopathology incident arose after administration of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine. Specifically, a transient purpuric interface dermatitis occurred 5 days post-second vaccine with the presentation of erythematous papules with erythema multiforme-type findings. A patient developed purpuric interface dermatitis with micro-vesiculation post-vaccination which ultimately resolved without sequelae.
摘要：
在施用mRNA-1273SARS-CoV-2（Moderna）疫苗后，出现了独特的皮肤病理学事件。具体来说,第2次疫苗接种后5天出现短暂性紫癜性界面性皮炎,出现红斑丘疹,并有多形红斑.一名患者在疫苗接种后出现了紫癜性界面性皮炎，并伴有微囊泡，最终没有后遗症。
